SMA patients have insufficient levels of the SMN protein, a situation triggering lower motor neuron degeneration and profound muscle weakness that restricts mobility and, in severe cases, results in respiratory failure and death [1]. Here, SMN2 is linked to proximal spinal muscular atrophy.